Cover Image
市場調查報告書

qPCR及dPCR器具的全球市場

qPCR and dPCR Instrumentation

出版商 Global Industry Analysts, Inc. 商品編碼 290727
出版日期 內容資訊 英文 257 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
qPCR及dPCR器具的全球市場 qPCR and dPCR Instrumentation
出版日期: 2018年01月01日 內容資訊: 英文 257 Pages
簡介

本報告提供全球qPCR及dPCR設備市場相關調查,彙整市場概要和競爭趨勢,產品概要,各地區的趨勢,及加入此市場的主要企業的簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 聚合酵素鏈鎖反應:基因擴增和定量的重要部分
    • 市場規模
    • 發展中國家巨大發展潛力
    • qPCR為主流技術
    • 研究與檢查:主要的應用市場 其他
  • 促進成長要素,市場趨勢,課題
    • 癌症的發病率,罹患率的上升
    • 醫療費擴大促進需求
    • 分子診斷的進步擴大遺傳基因放大技術的需求
    • 預測的遺傳基因診斷與檢查領域的樂觀預測
    • 遺傳基因疾病,感染疾病的罹患率上升
    • 擴大功能性與引進的技術創新 其他
  • 競爭環境
  • 最終用途市場分析
    • PCR的應用領域
    • 醫療和診斷
    • PCR在感染疾病診斷中的重要作用
    • 抗生素抗藥性的檢測
    • 司法鑑定,親子鑑定實驗
    • 食品安全
    • 與食品病原體的檢測定量化 其他
  • 產品概要
  • 產品技術創新/引進
  • 近幾年的產業活動
  • 主要企業
    • Agilent Technologies, Inc.
    • Becton, Dickinson and Company
    • BioFire Diagnostics, Inc.
    • Bio-Rad Laboratories, Inc.
    • Cepheid
    • Eppendorf AG
    • F. Hoffmann-La Roche Ltd.
    • Fluidigm Corporation
    • Promega Corporation
    • QIAGEN N.V.
    • RainDance Technologies, Inc.
    • TaKaRa BIO株式會社
    • Thermo Fisher Scientific Inc
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 南美

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-7856

This report analyzes the worldwide markets for qPCR and dPCR Instrumentation in US$ Thousand by the following Product Categories: Reagents, and Instruments. Also, the report analyzes the Global market by the following Product Categories, Product Segments, and End-Use Segments: Product Categories - Reagents, Instruments; Product Segments - qPCR (quantitative Polymerase Chain Reaction), and dPCR (digital Polymerase Chain Reaction); End-Use Segments - Educational/Research, Testing Laboratories, and Pharma. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 36 companies including many key and niche players such as -

Agilent Technologies, Inc.
Becton, Dickinson and Company
BioFire Diagnostics, Inc.
Bio-Rad Laboratories, Inc.
Cepheid
Eppendorf AG

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of the Study
    • qPCR
    • dPCR

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification
  • Sizing the Market
  • Developing Countries Exude Tremendous Potential for Growth
  • qPCR Remains the Mainstay Technology
  • Research and Testing - Major Application Markets
  • Striking the Right Balance between qPCR and Dpcr in Research Laboratories
  • qPCR- A Suitable Tool for Gene Expression and Validation
    • A Peek into Select qPCR Systems Available in Marketplace
      • Thermo Fisher Life Sciences Prism 7000 Series
      • Thermo Fisher Life Sciences ViiA 7
      • Thermo Fisher Life Sciences QuantStudio
      • Cepheid SmartCycler Platform
      • Roche LightCycler Platform
      • Roche FLOW
  • As qPCR Technology Matures, Saturation is Imminent
    • Table 1: Global qPCR Instrumentation Market by Category (2017): Percentage Share Breakdown of Annual Revenues for Reagents and Instruments (includes corresponding Graph/Chart)
  • Digital PCR to Take Quantification of Nucleic Acids to the Next Level
    • dPCR - A Valuable Tool in Virology Research
      • High Sensitivity in Viral Detection
      • Creation and Validation of Viral Reference Standards
      • High-Precision Quantification
    • Sales of Digital PCR to Skyrocket in the Near Term
    • dPCR Holds Potential to Capture Application Markets from Predecessor Technologies
    • New dPCR Systems to Capture a Bigger Slice of the Market
    • Table 2: A Comparison of Select Leading dPCR Systems
      • QuantStudio 3D Digital PCR System
      • QuantStudio 12K
      • BioMark HD system
      • QX100 droplet digital PCR System
      • RainDrop Systems
    • High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR
  • Despite Onslaught of Digital PCR, qPCR Maintains Relevance

2. GROWTH DRIVERS, MARKET TRENDS & ISSUES

  • Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR
    • Table 3: Worldwide Incidence of Cancer (2010, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
    • Table 4: New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 5: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 6: Cancer Incidence in High Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 7: Cancer Incidence in Upper Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 8: Cancer Incidence in Lower Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 9: Cancer Incidence in Low Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
  • Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests
    • Table 10: Healthcare Spending as % of GDP by Region (2016E) (includes corresponding Graph/Chart)
  • Progress in Molecular Diagnostics Spur Demand for the Gene Amplification Technologies
  • Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter
  • Growing Prevalence of Genetic Disorders and Infectious Diseases Provide a Strong Case for Growth
  • Innovations in Instrumentation Expand Functionality and Drive Adoption
  • Adaptive PCR - A Recent Advancement
  • Expanding Scope of Applications in Applied Sciences Drive Demand for qPCR Instruments and Supplies
  • qPCR and NGS to Drive Single-Cell Genomics Market
  • Advancements in Probe Technology Enhance qPCR Sensitivity
  • qPCR Market to Witness Increasing Affinity for Automated and Robotic Equipment
    • Factors influencing Selection of Lab Robots
  • Lab on Chip/Microfluidic Real-time-PCR - A Game Changer in the Offing
    • Two Types of Microfluidic Designs
    • Advantages of Lab on Chip PCR
    • Roadblocks in the Path to Development
    • New Developments in Lab-on-chip PCR
  • dPCR for Liquid Biopsies
  • Areas of Digital PCR has Immense Potential
  • ddPCR - The More Advanced Digital Approach to dPCR
    • Droplet digital PCR Finds Increasing Application in Life Sciences Research
    • ddPCR Gains Traction in Cancer Diagnosis
    • Monitoring Disease Progression in HIV Studies
    • Analysis of Genetically Modified Organisms in Edible Products
    • RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples
  • Adoption of High Throughput Platforms Gains Pace
  • MC-ICP, A New Technique for Increasing Sensitivity of dPCR Instruments
  • Study Establishes High Reproducibility of dPCR
  • Clarity(tm) dPCR - An Advanced dPCR for Improved Workflows
  • Veterinary Diagnostic Applications Yet to Embrace dPCR
  • Researchers Continue to Campaign for Adoption and Strict Compliance with MIQE and SPIDIA Guidelines
  • Alternate Technologies Pose Threat to Growth of PCR Market
  • New Isothermal PCR Technology - A Potential Game Changer Promising Faster PCR

3. COMPETITIVE LANDSCAPE

  • qPCR - A Highly Concentrated Market Place
  • Select qPCR Products by Company
    • Table 11: PCR Systems Product Portfolio of Thermo Fisher Life Sciences Solutions
  • Cost of PCR instruments and Reagents to Come Under Pressure
  • Competitive Landscape of dPCR Market
  • Bio-Rad Makes Rapid Strides in Life Science Arena with Two Big Deals
  • Qiagen Strengthens its Hold with Acquisitions
  • Intense Competition Triggers a Spate of M&A
  • Multiple Factors to Sustain Consolidation Trend in PCR Industry
  • Accelerated Commercialization of Products
  • Offering Integrated and Multi-technology Solutions
  • Manufacturers Step-Up Online Exposure
  • Manufacturers Target Expansion of Distribution Reach and Global Footprint

4. END-USE MARKET ANALYSIS

  • Application Areas of PCR
  • Medical and Diagnostics
  • PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
  • Detection of Antimicrobial Resistance
    • PCR-Based Nucleic Acid Amplification for Detection of Antimicrobial Agents
  • Forensic and Paternity Testing
  • Food Safety
  • Detection and Quantification of Food Pathogens
  • Detection of Beneficial and Non-Pathogenic Microbes
  • Study of Microbial Responses to Environment
  • Microbial Risk Assessment
    • qPCR Application in Food Microbiology: Study of Select Micro-Organisms by Target Gene and Food Substrate
  • PCR Technique in Identification of GMOs
  • Research & Academics
  • SYBR Dye and TaqMan Techniques Popular in Research Publications

5. PRODUCT OVERVIEW

  • Introduction to Polymerase Chain Reaction (PCR)
  • Reagents and Components Required for PCR
  • Reaction Steps
  • Denaturation
  • Annealing
  • Extension
  • Real-Time PCR or Quantitative PCR (qPCR)
  • qPCR Instrumentation
    • Evolution
    • Working of qPCR Instruments
      • Thermal Control
      • Fluorimetry
      • DNA Detection Methods
      • Fluorescence Measurement
      • Asymmetrical dsDNA dyes
      • Quantification
  • High-Throughput qPCR
  • Comparison of Working of Conventional PCR versus qPCR
  • Drawbacks in Core PCR
  • Advantages of qPCR
  • Disadvantages of qPCR
  • End-Use Applications of qPCR
  • Factors Influencing Purchase Decisions of qPCR Systems
  • qPCR Consumables, Accessories and Software
  • DIGITAL PCR
  • Development of dPCR
  • Working Principle
  • Droplet dPCR
  • Applications of dPCR
  • Advantages of dPCR

6. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Bio-Rad Rolls Out New RT-PCR Kit for Simultaneous Screening of Various Viruses
  • Agilent Technologies Launches AriaDx Real-Time PCR System
  • FORMULATRIX Introduces CONSTELLATION(r) Digital PCR System
  • Roche Rolls Out cobas(r) Liat(r) PCR System in Europe
  • Thermo Fisher Launches QuantStudio 5 RT PCR System
  • RainDance Introduces RainDrop Plus(tm) Digital PCR System
  • Stilla Launches Digital PCR System
  • Analytik Jena Unveils qTOWER³ RT PCR Thermal Cycler
  • Bio-Rad Rolls Out ddPCR(tm) Supermix
  • Takara Bio Unveils Thermal Cycler Dice(r) Real Time System III
  • Exiqon Introduces ExiLERATE LNA(tm) qPCR Reagents and Kits
  • Thermo Fisher Launches PowerUp SYBR Green PCR Master Mix
  • Thermo Fisher Introduces QuantStudio 3 and QuantStudio 5 RT PCR Systems
  • Kapa Biosystems Rolls Out KAPA PROBE FORCE qPCR Kit
  • Agilent Technologies Launches AriaMx System

7. RECENT INDUSTRY ACTIVITY

  • RainDance and Bio-Rad Ink Definitive Acquisition Agreement
  • Curetis Buys Gyronimo Platform from Carpegen and Systec
  • QIAGEN Takes Over Exiqon
  • LGC Takes Over Douglas Scientific
  • Bio-Rad Secures CE Marking for QX200(tm) Droplet Digital(tm) PCR System
  • Roche to Take Over Kapa Biosystems
  • LGC to Acquire Biosearch
  • Thermo Fisher Scientific Completes Take Over of Life Technologies

8. FOCUS ON SELECT PLAYERS

  • Agilent Technologies, Inc. (USA)
  • Becton, Dickinson and Company (USA)
  • BioFire Diagnostics, Inc. (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Cepheid (USA)
  • Eppendorf AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Fluidigm Corporation (USA)
  • Promega Corporation (USA)
  • QIAGEN N.V. (Netherlands)
  • RainDance Technologies, Inc. (USA)
  • Takara Bio, Inc. (Japan)
  • Thermo Fisher Scientific Inc. (USA)

9. GLOBAL MARKET PERSPECTIVE

    • Table 12: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for qPCR and dPCR Instrumentation and Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 14: World 14-Year Perspective for qPCR and dPCR Instrumentation and Reagents by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
  • Analytics by Product Category
    • Table 15: World Recent Past, Current & Future Analysis for qPCR and dPCR Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 16: World Historic Review for qPCR and dPCR Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 17: World 14-Year Perspective for qPCR and dPCR Reagents by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 18: World Recent Past, Current & Future Analysis for qPCR and dPCR Instruments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 19: World Historic Review for qPCR and dPCR Instruments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 20: World 14-Year Perspective for qPCR and dPCR Instruments by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
  • Analysis by Product Segment
    • Table 21: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by Product Segment - qPCR and dPCR Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 22: World Historic Review for qPCR and dPCR Instrumentation and Reagents by Product Segment - qPCR and dPCR Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 23: World 14-Year Perspective for qPCR and dPCR Instrumentation and Reagents by Product Segment - Percentage Breakdown of Revenues for qPCR and dPCR Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 24: World Recent Past, Current & Future Analysis for qPCR Instrumentation and Reagents by Product Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 25: World Historic Review for qPCR Instrumentation and Reagents by Product Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 26: World 14-Year Perspective for qPCR Instrumentation and Reagents by Product Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 27: World Recent Past, Current & Future Analysis for dPCR Instrumentation and Reagents by Product Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 28: World Historic Review for dPCR Instrumentation and Reagents by Product Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 29: World 14-Year Perspective for dPCR Instrumentation and Reagents by Product Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
  • Analytics by End-Use
    • Table 30: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by End-Use Segment - Educational/ Research, Testing Laboratories and Pharma Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 31: World Historic Review for qPCR and dPCR Instrumentation and Reagents by End-Use Segment - Educational/Research, Testing Laboratories and Pharma Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 32: World 14-Year Perspective for qPCR and dPCR Instrumentation by End-Use Segment - Percentage Breakdown of Revenues for Educational/Research, Testing Laboratories and Pharma Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
    • qPCR Vs. dPCR Instrumentation is the US
    • Cancer Stats
      • Cancer Incidence Statistics
    • Table 33: New Cancer Cases by Gender and Affected Site in the US (2017E) (includes corresponding Graph/Chart)
    • Table 34: Cancer Related Deaths by Gender in the US (2017E) (includes corresponding Graph/Chart)
    • Table 35: New Cancer Cases by State in the US (2017E) (includes corresponding Graph/Chart)
      • Cancer Mortality Statistics
    • Table 36: Cancer Related Deaths in the US by Gender and Body Site: 2017 (includes corresponding Graph/Chart)
    • Table 37: Number of Deaths Related to Major Types of Cancer in US by State: 2017E (includes corresponding Graph/Chart)
    • Competitive Landscape
    • Product Introductions
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 38: The US Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 39: The US Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 40: The US 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current and Future Analysis
    • Cancer Statistics in Canada
    • Table 41: New Cancer Cases in Canada (2017E): Breakdown of Cancer Incidence by Gender and Affected Site (includes corresponding Graph/Chart)
    • Table 42: New Cancer Cases in Canada by Province: 2017E (includes corresponding Graph/Chart)
    • Table 43: New Cancer Cases in Canada by Age Group: 2017E (includes corresponding Graph/Chart)
    • Table 44: Cancer Related Deaths in Canada (2017E): Percentage Breakdown of Number of Deaths by Gender and Affected Site (includes corresponding Graph/Chart)
    • Funglyn Biotech, Inc. - A Key Player
  • B. Market Analytics
    • Table 45: Canadian Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 46: Canadian Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 47: Canadian 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
    • Takara Bio, Inc. - A Key Player
  • B. Market Analytics
    • Table 48: Japanese Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 49: Japanese Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 50: Japanese 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • PCR Reagents in Europe: An Overview
    • qPCR Competitive Landscape
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 51: European Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 52: European Historic Review for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 53: European 14-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, and Rest of Europe Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 54: European Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 55: European Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 56: European 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
  • B. Market Analytics
    • Table 57: French Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 58: French Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 59: French 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
    • Strategic Corporate Development
    • Eppendorf Ag - A Key German Player
  • B. Market Analytics
    • Table 60: German Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 61: German Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 62: German 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 63: Italian Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 64: Italian Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 65: Italian 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • Market Analysis
    • Table 66: The UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 67: The UK Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 68: The UK 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4e. REST OF EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launches
    • Strategic Corporate Development
    • Key Players
  • B. Market Analytics
    • Table 69: Rest of Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 70: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 71: Rest of Europe 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • Market Analysis
    • Table 72: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 73: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 74: Asia-Pacific 14-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Revenues for China and Rest of Asia-Pacific Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 75: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 76: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 77: Asia-Pacific 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5a. CHINA

  • Market Analysis
    • Table 78: Chinese Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 79: Chinese Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 80: Chinese 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5b. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • India
      • Market Overview
      • Traditional PCRs Still Rule the Indian PCR Market
    • Table 81: Indian PCR Systems Market by Type (2017E): Percentage Breakdown of Market Value and Volume for RT PCRs and Traditional PCRs (includes corresponding Graph/Chart)
    • Table 82: Indian PCR Systems Market by End-Use Industry (2017E): Percentage Breakdown of Sales for Biopharma, Diagnostics and Life Sciences & Biotech (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 83: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 84: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 85: Rest of Asia-Pacific 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

6. MIDDLE EAST & AFRICA

  • Market Analysis
    • Table 86: The Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 87: The Middle East Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 88: The Middle East 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

7. LATIN AMERICA

  • Market Analysis
    • Table 89: Latin American Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 90: Latin American Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 91: Latin American 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top